Latest from Pharma in Focus

Posted: 13.12.2017
Who was quickest to PBS in 2017? 
Reimbursement: The road to reimbursement can be a sprint or a marathon, the latest Pharma in Focus analysis of 2017 PBS listings found.
CAR-Ts poised to shakeup blood cancer 
Pipeline: Innovative therapies headlined the 59th American Society of Hematology meeting this week with new treatments promising to challenge current regimes.
Mabthera successor expands access 
Market Access: December has kicked off with extensions to two registered drugs, including Roche's Gazyva which is lining up to succeed the company's expiring Mabthera.
Weekes resigns as NPS CEO 
Leadership: After almost 20 years at the helm of NPS Medicinewise, Dr Lynn Weekes has resigned, effective mid-2018.
Stop OTC pain claims, court tells AFT 
Litigation: The Federal Court has told AFT it can't claim paracetamol/ibuprofen OTC combo Maxigesic is better than the competition - at least not yet.

read more

© 2008-2017 Powered by SmartJobBoard Job Board Software     About Us   Sitemap